Solventum Corp

Solventum Corp is a U.S.-based healthcare company that develops, manufactures, and commercializes products used across prevention, diagnosis, treatment, and recovery. Its portfolio spans medical devices, dental solutions, health information systems, and purification and filtration technologies, with customers served in the United States and international markets.

32,1 %

53,5 %

18,7 %

+0,9 %

1.23

0.89

— Solventum Corp
%
MedSurg45% Medical and surgical products used in hospitals and other care settings.
Dental Solutions15% Products and technologies used by dental professionals and clinics.
Health Information Systems20% Software and digital workflow tools for healthcare documentation and data use.
Purification and Filtration20% Filtration and purification products for healthcare and industrial applications.

Solventum sells primarily to healthcare providers and related institutions that need regulated products, clinical...

  • Hospitals and health systemsprimary

    Buy MedSurg products and HIS tools to support clinical care, workflow, and patient safety.

  • Dental practices and dental groupssecondary

    Buy dental materials and equipment used in routine and specialized dental care.

  • Clinics and physician practicessecondary

    Buy healthcare products and systems for day-to-day treatment and documentation needs.

  • Healthcare and industrial filtration customerssecondary

    Buy purification and filtration products for controlled-process applications.

Solventum operates globally, with sales split between the United States and international markets...

  • United States represented 56.1% of 2025 net sales
  • International represented 43.9% of 2025 net sales
  • Sales are reported by customer location or service location
  • Global operations expose the company to local regulation and pricing
  • International business adds currency and compliance complexity

Solventum’s strategy centers on building a standalone healthcare platform around its core product families, while...

01
Standalone operating modelmedium-term

A separate corporate structure requires independent systems, brand building, and operating discipline.

02
Manufacturing and sourcing resiliencemedium-term

Healthcare products depend on reliable supply, qualified components, and compliant facilities.

03
Innovation and product developmentlong-term

Differentiated products and digital tools support customer retention and market access.

04
Regulatory and quality compliance

Medical and pharmaceutical products require approvals, inspections, and ongoing compliance.

Solventum faces regulatory, quality, supply chain, and cybersecurity risks typical of a regulated healthcare...

high

Regulatory approval and compliance risk

Products are subject to FDA and non-U.S. medical device and pharmaceutical rules.

Scope
Global product portfolio
Materiality
high
high

Product quality and recall risk

Defects or improper use can trigger recalls, safety alerts, and lost sales.

Scope
MedSurg and other regulated products
Materiality
high
high

Supply chain and sole-source supplier risk

Interrupted supply or component shortages can prevent timely customer delivery.

Scope
Manufacturing and sourced components
Materiality
high
medium

Cybersecurity and IT risk

Healthcare data and proprietary systems are attractive targets and operationally sensitive.

Scope
Health Information Systems and corporate systems
Materiality
medium
medium

Pricing pressure and customer consolidation

Large healthcare buyers can negotiate harder and exclude suppliers.

Scope
Hospitals, distributors, and healthcare systems
Materiality
high
medium

Geopolitical and trade risk

International operations face tariffs, local policy shifts, and cross-border disruption.

Scope
International markets
Materiality
medium
Goodwill and intangible asset impairment
Could create non-cash charges if assumptions weaken
Legal proceedings and contingencies
Affects operating expenses and liabilities
Hedging and foreign currency accounting
Can affect earnings volatility and OCI
Carve-out and separation accounting
Limits comparability across periods

: 11/08/2026